CAR-T Cell Advancements: How are gene cell therapies benefiting from technology designed for IVF clinics?

As pharma manufacturing evolves to cell and gene therapies, how can technology help address the unique quality control issues? Click the video above to hear insights from an expert panel including LifeAire CEO and Founder, Dr. Kathryn C. Worrilow, joined by:

  • Boro Dropulic, Ph.D., Chief Science Officer and General Manager, Lentigen
  • Ali Mohamed, PhD, VP, CMCImmatics Biotechnologies
  • Heidi Hagen, Chief Strategy Officer, Vineti
  • Peter Olagunju, Vice President Patient Operations & Lentiglobin Program Leader, Bluebird Bio